Clinical trial Recruiting at 1 site Interventional

Evaluating dietary supplements and exercise for patients with sarcopenia and lung disease

Official title: Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study

Run by Orient Europharma Co., Ltd. · NCT05926713 · Data updated 2026-11-12

This study is testing whether a combination of dietary supplements and supervised exercise can help people with sarcopenia and lung diseases like COPD and ILD improve their physical performance and lung function.

Quick facts

Study typeInterventional
SexAll
Enrollment100 (estimated)
SponsorOrient Europharma Co., Ltd.
Industry-sponsored
Locations1 site (Taichung)
StatusRecruiting
StartedMarch 1, 2023
Main results expectedOctober 31, 2032
Study endsOctober 31, 2032
Registry record updatedJuly 3, 2023
Trial IDNCT05926713 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include outpatients diagnosed with COPD or ILD who also meet the criteria for sarcopenia.

Probably not a fit

Patients who are bedridden, under 20 years old, or have terminal illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a prospective, multi-center study aimed at assessing the effects of dietary supplements combined with supervised exercise on physical performance, body composition, and lung function in patients suffering from sarcopenia associated with chronic lung diseases such as COPD and ILD. Participants will undergo a 12-week intervention, after which their improvements will be analyzed to provide insights into effective clinical interventions for rehabilitation. The study will also track participants for an additional year to evaluate long-term benefits of the nutritional supplements provided.

Why it matters

Potential benefit: If successful, this study could enhance physical performance and lung function in patients with sarcopenia and chronic lung disease.

How similar studies have gone: Other studies have shown promising results with similar interventions combining exercise and nutritional support for sarcopenia, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
* Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.

Exclusion Criteria:

* Patients who refuse to sign the consent form
* Patients who are under 20 years old
* Patients who are bedridden or unable to walk due to physical disabilities
* Patients with terminal cancer or human-acquired immunodeficiency syndrome
* Patients with edema (grading pitting edema +2)

Where it's running

  • Taichung Veterans General Hospital
    Taichung, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Pin-Kuei Fu — Department of Chest Medicine of Taichung Veterans General
  • Study coordinator: Pin-Kuei Fu, PhD
  • Email: yetquen@vghtc.gov.tw
  • Phone: 04-23592525

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.